Catherine Ramsey
Stock Analyst at Baird
(3.07)
# 1,332
Out of 4,989 analysts
51
Total ratings
38.46%
Success rate
5.31%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Catherine Ramsey
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
ILMN Illumina | Maintains: Neutral | $84 → $105 | $99.37 | +5.67% | 6 | Jul 28, 2025 | |
WAT Waters | Maintains: Outperform | $374 → $352 | $299.22 | +17.64% | 11 | Jul 16, 2025 | |
TWST Twist Bioscience | Maintains: Outperform | $54 → $44 | $27.64 | +59.19% | 7 | May 6, 2025 | |
RVTY Revvity | Maintains: Outperform | $127 → $125 | $85.62 | +46.00% | 5 | Apr 29, 2025 | |
NTRA Natera | Maintains: Outperform | $183 → $188 | $172.83 | +8.78% | 6 | Feb 28, 2025 | |
CSTL Castle Biosciences | Maintains: Outperform | $36 → $37 | $23.58 | +56.91% | 8 | Feb 28, 2025 | |
TMO Thermo Fisher Scientific | Maintains: Outperform | $695 → $665 | $469.75 | +41.56% | 2 | Nov 1, 2022 | |
A Agilent Technologies | Maintains: Outperform | $155 → $160 | $125.94 | +27.04% | 5 | Aug 17, 2022 | |
EXAS Exact Sciences | Maintains: Outperform | $90 → $75 | $52.41 | +43.10% | 1 | Aug 3, 2022 |
Illumina
Jul 28, 2025
Maintains: Neutral
Price Target: $84 → $105
Current: $99.37
Upside: +5.67%
Waters
Jul 16, 2025
Maintains: Outperform
Price Target: $374 → $352
Current: $299.22
Upside: +17.64%
Twist Bioscience
May 6, 2025
Maintains: Outperform
Price Target: $54 → $44
Current: $27.64
Upside: +59.19%
Revvity
Apr 29, 2025
Maintains: Outperform
Price Target: $127 → $125
Current: $85.62
Upside: +46.00%
Natera
Feb 28, 2025
Maintains: Outperform
Price Target: $183 → $188
Current: $172.83
Upside: +8.78%
Castle Biosciences
Feb 28, 2025
Maintains: Outperform
Price Target: $36 → $37
Current: $23.58
Upside: +56.91%
Thermo Fisher Scientific
Nov 1, 2022
Maintains: Outperform
Price Target: $695 → $665
Current: $469.75
Upside: +41.56%
Agilent Technologies
Aug 17, 2022
Maintains: Outperform
Price Target: $155 → $160
Current: $125.94
Upside: +27.04%
Exact Sciences
Aug 3, 2022
Maintains: Outperform
Price Target: $90 → $75
Current: $52.41
Upside: +43.10%